SEC Form 4 · accession 0001144204-17-031784
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward Raymond Jones
Director
Period of report
Jun 8, 2017
Accepted (ET)
Jun 8, 2017 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2017 | P | 500 | $3.975 | A | 500 | D | |
| Common StockF1 | Jun 8, 2017 | P | 2,000 | $3.9995 | A | 68,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes (i) the following restricted stock units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 6,000 RSUs granted on February 24, 2017, (b) 5,000 RSUs granted on June 7, 2016, and (c) 55,000 RSUs granted on April 8, 2015, and (ii) 2,500 shares of common stock purchased by the reporting person in the open market and reported on this Form 4.